Abpro Holdings Celebrates Nasdaq Bell Ringing Ceremony
12 Dec 2024 //
GLOBENEWSWIRE
Abpro Announces Filing of Registration Statement on Form S-4
22 Jan 2024 //
GLOBENEWSWIRE
Abpro inks SPAC deal to fund bispecific R&D years after axed IPO
22 Sep 2023 //
FIERCE BIOTECH
Abpro to Partnership with Celltrion for Development of a Antibody
22 Sep 2022 //
BUSINESSWIRE
Abpro Reports Its ABP 310 COVID Antibody Retains Neutralization Activity Against
09 Dec 2021 //
GLOBENEWSWIRE
Abpro to present data at the 2021 ARVO of ABP201
04 May 2021 //
GLOBENEWSWIRE
Abpro Announces Positive Phase 1 Results Demonstrating A Favorable Safety
02 Feb 2021 //
GLOBENEWSWIRE
Abpro Announces Initiation of Phase 2/3 Studies of its Neutralizing
16 Dec 2020 //
GLOBENEWSWIRE
Abpro Announces Peer-Reviewed Publication Demonstrating Efficacy
16 Nov 2020 //
YAHOO